ZULIANI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 1.735
EU - Europa 1.718
AS - Asia 803
SA - Sud America 87
AF - Africa 26
Totale 4.369
Nazione #
US - Stati Uniti d'America 1.700
CN - Cina 477
FI - Finlandia 360
SE - Svezia 278
IE - Irlanda 261
SG - Singapore 249
IT - Italia 220
UA - Ucraina 194
DE - Germania 167
BR - Brasile 76
NL - Olanda 70
GB - Regno Unito 53
TR - Turchia 43
RU - Federazione Russa 38
CA - Canada 32
CI - Costa d'Avorio 23
BE - Belgio 20
AT - Austria 18
IN - India 12
CZ - Repubblica Ceca 11
FR - Francia 10
IQ - Iraq 6
PT - Portogallo 6
LT - Lituania 5
CL - Cile 3
HK - Hong Kong 3
AR - Argentina 2
EC - Ecuador 2
EE - Estonia 2
ID - Indonesia 2
IR - Iran 2
MA - Marocco 2
NP - Nepal 2
VE - Venezuela 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BH - Bahrain 1
CO - Colombia 1
CY - Cipro 1
EG - Egitto 1
ES - Italia 1
GY - Guiana 1
JO - Giordania 1
LI - Liechtenstein 1
MX - Messico 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
Totale 4.369
Città #
Chandler 279
Dublin 261
Jacksonville 214
Singapore 152
Santa Clara 139
Ann Arbor 119
Ashburn 114
Beijing 107
Dearborn 101
Boardman 83
Nanjing 82
Parma 63
Princeton 51
Shanghai 51
Helsinki 42
Izmir 41
San Mateo 40
Milan 37
New York 36
Wilmington 35
Toronto 29
Bremen 25
Moscow 25
Shenyang 24
Abidjan 23
Hebei 23
Los Angeles 23
Nanchang 22
Brussels 20
Jinan 20
Munich 20
Kunming 19
Vienna 18
Hefei 16
Des Moines 13
Seattle 13
Guangzhou 12
Jiaxing 12
Woodbridge 12
Council Bluffs 8
Frankfurt am Main 8
Auburn Hills 7
Changsha 7
Norwalk 7
Nuremberg 7
Pune 7
Tianjin 7
Brno 6
Chengdu 6
London 6
Piacenza 6
Reggio Emilia 6
Bologna 5
Dallas 5
Falkenstein 5
Haikou 5
Marseille 5
Modena 5
Reggio Nell'emilia 5
The Dalles 5
Abbiategrasso 4
Belo Horizonte 4
Brescia 4
Falls Church 4
Roncadelle 4
Taiyuan 4
Amsterdam 3
Augusta 3
Baghdad 3
Borås 3
Buccinasco 3
Castelo Branco 3
Düsseldorf 3
Grafing 3
Gualtieri 3
Hangzhou 3
Houston 3
Leipzig 3
Pavia 3
St Andrews 3
Taizhou 3
Xian 3
Zhengzhou 3
Caracas 2
Castelcovati 2
Cereda 2
Cesena 2
Chongqing 2
Contagem 2
Espoo 2
Fairfield 2
Florence 2
Fuzhou 2
Hertford 2
Jakarta 2
Kathmandu 2
Lanzhou 2
Magdeburg 2
Miami 2
Montepulciano 2
Totale 2.653
Nome #
2-Aminobenzimidazoles as new potent H3-antagonists 129
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 111
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 109
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 108
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity 107
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 106
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 105
Aminobenzimidazoles as new potent H3-antagonists 104
Synthesis and 3D-QSAR Analysis of H3 Receptor Antagonists Containing a Neutral Heterocyclic Polar Group 103
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 101
Antiproliferative and proapototic effects of a new combi-molecule on non small cell lung cancer cell lines 101
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 98
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 95
CNS access of selected H3-antagonists: ex vivo binding study in rats 93
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 91
5-benzylidene-hydantoin UPR 1024 acts as EGFR inhibitor and induces DNA damage in A549 NSCLC cell line 91
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 90
Drug repurposing approaches to fight Dengue virus infection and related diseases 90
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 90
Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain 89
5-benzylidene-hydantoins as new inhibitors of cell proliferation 89
Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines 86
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 86
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 86
Chiral NMR discrimination of the diastereoisomeric salts of the H(3)-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole. 85
2,4(5)-Diarylimidazoles: Synthesis and Biological Evaluation of a New Class of Sodium Channel Blockers against hNav1.2 80
Advances in Design and Development of Sodium Channel Blockers. 80
Structure-Property Relationships on Histamine H3-Antagonists: Binding of Phenyl-substituted Alkylthioimidazole Derivatives to Rat Plasma Proteins 78
Histamine H3-antagonists: the basicity of the polar group in quantitative structure-activity and structure-property relationship 78
Relationship between structure and ex-vivo binding of imidazole H3 antagonists to rat brain H3 receptors 75
Three-Dimensional Quantitative Structure-Activity Relationship Studies on Selected MT1 and MT2 Melatonin Receptor Ligands: Requirements for Subtype Selectivity and Intrinsic Activity Modulation 75
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 75
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 75
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry 75
Anticonvulsant Activity of 2,4(5)-Diarylimidazoles in Mice and Rat Models 74
NMR Analysis of a Series of Imidazobenzoxazines 73
2,4(5)-Diarylimidazoles as Inhibitors of hNaV1.2 Sodium Channels: Pharmacological Evaluationand Structure-Property Relationships 72
Anticonvulsant Activity of 2,4(1H)-Diarylimidazoles in Mice and Rats Acute Seizure Models 70
Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers 69
Sodium Channel Blocking Activity and In-vivo Testing of New Phenyl-imidazole Derivatives. 68
A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks 63
Sodium channel blockers: a patent review (2010 - 2014) 63
Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential 61
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 61
Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates 60
NEW ALKBH2 AND ALKBH5 INHIBITORS FOR TREATING GLIOBLASTOMA 59
In vivo Screening of Diarylimidazoles as Anticonvulsant Agents 58
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 58
Sodium channel blockers for neuropathic pain. 56
Microwave Assisted Efficient Synthesis of Imidazole-based Privileged Structure 53
Fluorescent Ligands for the Histamine H2 Receptor: Synthesis and Preliminary Characterization 50
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 49
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 47
null 36
pH-partition profiles of 4-(3-oxo-1,2-benzisothiazolin-2-yl)phenyl and phenoxyalkanoic acids 35
Erratum: Fluorescent ligands for the histamine H 2 receptor: Synthesis and preliminary characterization (Bioorganic & Medicinal Chemistry (2004) 12 (6495-6503)) 33
IMIDAZOBENZOXAZIN-5-THIONE (MV1035) TO OVERCOME THE BLOOD-BRAIN BARRIER AND TARGET CNS DISEASES 31
Totale 4.433
Categoria #
all - tutte 18.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202077 0 0 0 0 0 0 0 0 0 0 22 55
2020/2021374 6 52 35 12 43 6 54 11 73 16 61 5
2021/2022251 2 5 6 20 11 8 33 35 15 18 27 71
2022/20231.103 119 120 83 76 101 143 19 46 322 16 40 18
2023/2024400 14 41 13 11 39 96 40 23 17 23 31 52
2024/2025949 56 83 101 115 67 143 52 84 108 131 9 0
Totale 4.433